About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Out Of 17,000 Drug Samples Collected Globally, 41% Failed To Meet Quality Standards

by Bidita Debnath on April 21, 2015 at 11:32 PM
Font : A-A+

Out Of 17,000 Drug Samples Collected Globally, 41% Failed To Meet Quality Standards

With globalization blurring the line between domestic and foreign medicine production, poor quality medicines are a real and urgent global threat, claims a new research.

In global studies of about 17,000 drug samples, 41% of specimens failed to meet quality standards, the researchers reported. Prevalence of poor quality medicines could undermine decades of successful efforts to combat HIV/AIDS, malaria and tuberculosis.

Advertisement

"Today's medical-product landscape blurs the line between domestic and foreign production, drawing attention to the need for global quality and safety oversight to prevent patient exposure to falsified products," wrote Margaret Hamburg, foreign secretary of the Institute of Medicine, the health arm of the US National Academy of Sciences.

Scientists inspected the quality of about 16,800 samples of anti-malarials, anti-tuberculosis medicines, antibiotics and anti-leishmaniasis drugs and reported from 9 to 41% failed to meet the specifications.
Advertisement

Seven separate studies were carried out, primarily in low-resource settings, and included samples from public and private sources.

"The pandemic of falsified and substandard medicines is pervasive and underestimated, particularly in low and middle income countries, where drug regulatory systems are weak or non-existent," Jim Herrington from the University of North Carolina noted.

New methodologies to test drug quality are emerging and scientists reported the results of four investigations. Simple paper-based test cards proved to be an economical and portable method to identify very low quality anti-malarials.

More sophisticated approaches using fluorescent and luminescent techniques or other novel technologies can measure with greater precision but may be difficult to use in remote settings, the authors noted.

An urgent and coordinated international response is required to address the pandemic of poor quality drugs, the scientists maintained.

The findings were published online ahead of print by The American Journal of Tropical Medicine and Hygiene.

Source: IANS
Advertisement

Advertisement
Advertisement

Recommended Reading

Latest Drug News

 India's First Urinary Incontinence Drug Launched
India's First Urinary Incontinence Drug Fesobig may offer Affordable treatment for Overactive Bladder (OAB), a widely prevalent problem among Indian men and women.
 New Ray of Hope for Atrial Fibrillation Patients With Kidney Disease
Oral anticoagulant drugs, particularly Rivaroxaban presented superior efficacy and safety than warfarin in atrial fibrillation patients with chronic kidney disease.
Anti-viral Drug Bulevirtide Helps Treat Chronic Hepatitis D
Patients with hepatitis D virus-related chronic advanced liver disease are treated with an antiviral therapy.
Antiviral Drug Paxlovid Linked to Lower Risk of Hospital Admission
Among people with COVID-19, Paxlovid drug was found to reduce hospitalization and death risk by 90%, revealed study.
Price Cap Move Will Place Eli Lilly Strongly in Insulin Market
Lilly will likely maintain or increase its market share in the insulin space as the average out-of-pocket cost for its insulin products is already below the $35 price cap.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Out Of 17,000 Drug Samples Collected Globally, 41% Failed To Meet Quality Standards Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests